Neumentum
Morristown
About Neumentum
Neumentum neurology specialty pharmaceutical company that develops and commercializes novel non-opioid pain products. At Neumentum, we are dedicated to developing safe, effective treatment options that address unmet needs in the management of pain, without the potential risks of misuse, addiction, or life-threatening side effects that may be found with opioid products. Neumentum has global rights to five novel non-opioid pain products, the most advanced of which are two phase 3-ready injectable products under development for acute postsurgical pain.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $34.7M
- Last round: Series Unknown (Oct 2021)
- Website: neumentum.com
- Phone: 9082396142
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/neumentum-681 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.